Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HCFC1 antisense RNA 1 (HCFC1-AS1) is a long non-coding RNA (lncRNA), classified as an antisense transcript located at the HCFC1 gene locus[1][7]. It does not encode a protein and is affiliated with the regulation of gene expression, likely through epigenetic and post-transcriptional mechanisms that are characteristic of antisense RNAs[2][4][6]. HCFC1-AS1 has been associated with Rett syndrome, but its precise pathological or physiological functions are not fully characterized[1][7]. In general, members of this RNA class (antisense lncRNAs) can modulate sense transcript levels, influence chromatin state, affect mRNA processing, and contribute to both gene silencing and activation, often impacting disease by altering expression of nearby or distant genes[2][4][6]. Specific drugs targeting HCFC1-AS1 or directly modulating its activity are not currently documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HCFC1 antisense RNA 1 (non-protein coding) (HCFC1-AS1).